Wei Huanhuan Y, Fan Xiao-Juan, Mao Miao-Wei
Bio-med Big Data Center, CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, Shanghai, China.
University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, China.
Methods Mol Biol. 2025;2883:109-137. doi: 10.1007/978-1-0716-4290-0_5.
The mRNA vaccine has emerged as a powerful tool against viral infection during the coronavirus disease 2019 (COVID-19) pandemic. In the post-COVID-19 era, the applications of mRNA-based therapy continue to expand and evolve. Circular RNA (circRNA), long assumed to be a noncoding RNA, has been proven to be translatable and subsequently developed as a next-generation mRNA modality due to its higher stability and wider therapeutic window. Nonetheless, the studies of circRNA translation and its application in diseases still present numerous technical features and challenges. In this chapter, we provide a summary and discussion on the mechanisms of circRNA translation and its applications in medicine development, aiming to serve as a reference and inspiration for readers interested in circRNA-based therapy.
在2019年冠状病毒病(COVID-19)大流行期间,mRNA疫苗已成为对抗病毒感染的有力工具。在COVID-19后的时代,基于mRNA的疗法的应用不断扩展和演变。环状RNA(circRNA)长期以来一直被认为是一种非编码RNA,但已被证明可以翻译,并因其更高的稳定性和更宽的治疗窗口而随后被开发为下一代mRNA形式。尽管如此,circRNA翻译及其在疾病中的应用研究仍然存在许多技术特点和挑战。在本章中,我们对circRNA翻译机制及其在医学发展中的应用进行了总结和讨论,旨在为对基于circRNA的疗法感兴趣的读者提供参考和启发。